Yale Bulletin and Calendar

January 18, 2002Volume 30, Number 15Two-Week Issue



BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

YALE SCOREBOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Research reveals that quitting smoking impairs some cognitive function in schizophrenics

When schizophrenic patients quit smoking, some aspects of their cognitive function become impaired, according to a new study published by Yale researchers in the January issue of the Journal of Neuropsychopharmacology.

The researchers found that cigarette smoking improves a type of cognitive function called visuospatial working memory (VSWM) -- the ability to recall visual stimuli -- in patients with schizophrenia, but that smoking had no beneficial effects, or even negative effects, on this form of cognitive function in healthy subjects without schizophrenia.

"This is one of only a few studies to suggest that nicotine has a beneficial effect on spatial working memory, which is known to be impaired in schizophrenic patients," says principal investigator Dr. Tony P. George, assistant professor of psychiatry at the School of Medicine and the Connecticut Mental Health Center.

"The question still remains whether nicotine can improve VSWM in non-smoking schizophrenic patients, who -- based on our results -- have even worse spatial working memory function compared to smoking schizophrenics," George adds. "Proving this may be difficult due to ethical concerns about giving nicotine to non-smokers, given its addictive properties."

It is well known among researchers that patients with schizophrenia have high rates of cigarette smoking compared to the general population. Past animal studies have shown that nicotine has complex effects on spatial working memory, with most showing that nicotine improves it. George says schizophrenic patients might be smoking as a form of self-medication to alleviate cognitive dysfunction linked to low activity of the neurotransmitter dopamine in the prefrontal cortex (PFC), a part of the brain that is known to be abnormal in schizophrenics and may in part mediate performance on spatial working memory tasks. Since nicotine is known to increase dopamine levels in the PFC, cigarette smoking may normalize PFC dopamine levels, and improve spatial working memory deficits in these patients.

Using medications that help smokers quit, George and his team examined the effects of up to 10 weeks of smoking abstinence on a computerized test of VSWM. They tested 23 schizophrenic patients and 29 non-schizophrenic subjects, all of whom were dependent on cigarettes. They also examined VSWM function in eight non-smoking schizophrenic patients and 16 control subjects as a comparison to test the effects of smoking status on this cognitive function.

George says ongoing studies might eventually lead to the development of novel nicotine-like drugs that may improve cognitive dysfunction in schizophrenics, but without the health risks of tobacco smoking. Such nicotine receptor-stimulating drugs could eventually become potential new treatments for cognitive dysfunction in schizophrenia and other psychiatric disorders.

George recently received a three-year, $625,000 National Institute on Drug Abuse grant to continue his research in this area. With this new grant, he and his team are using a controlled human laboratory study to investigate how foregoing smoking overnight and then resuming smoking affects several aspects of cognitive dysfunction in both schizophrenic and non-psychiatric smokers. An investigational drug that blocks brain nicotine receptors is used to demonstrate that the ability of smoking to enhance cognition is due to stimulation of brain nicotine receptors. Preliminary results from this new study confirm the findings of this paper.

In addition to George, other authors on this study include Jennifer Vessicchio, research associate; Angelo Termine and Tom Pepper, research assistants; Deanna Sahady and Cory Head, Yale undergraduate students; Dr. Thomas R. Kosten, professor of psychiatry; and Dr. Bruce E. Wexler, professor of psychiatry.

-- By Karen Peart


T H I SW E E K ' SS T O R I E S

Yale and Unions agree to seek more effective negotiations process

Campus events honor legacy of Martin Luther King Jr.

Center receives over $12 million in grants for research on AIDS

IN FOCUS: Electrical Engineering

'Painted Ladies' of king's court featured in exhibition


MEDICAL SCHOOL NEWS

'Art for All Seasons' showcases works by Asian artists

Works depict the human form, both draped and undraped

'A Streetcar Named Desire' comes to the Yale stage

Petrarch's poetry will be highlighted in a campus talk . . .

Symposium to examine roots of modern visual culture

Woodcut offers panoramic view of 16th-century Muslim life


OBITUARIES

Funny things will happen during a Roman-style comedy week

Standing, Special and Appointments Committees

Yale seeks nominees for 2001 Seton Elm-Ivy Awards

Fellowships for foreign study and travel offered by YCIAS

Yale Books in Brief

Campus Notes



Bulletin Home|Visiting on Campus|Calendar of Events|In the News|Bulletin Board

Yale Scoreboard|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs Home|News Releases| E-Mail Us|Yale Home Page